Jensterle M, Rizzo M, Jane A
Gutbrain nutrient signaling
Phase 2 results (48 weeks): 1mg dose: 8.7% average weight loss 4mg dose: 17.1% average weight loss 8mg dose: 22.8% average weight loss 12mg dose: 24.2% average weight loss Placebo: 2.1% average weight loss These numbers came from a 48-week study period, six months shorter than the 72-week SURMOUNT trials
Many are runners, lifters, CrossFitters, or weekend athletes
In Simple Terms Used in research studying tissue repair and cellular migration pathways Often included in tendon, ligament, connective tissue, and wound-healing models Supports comparison of repair-signaling activity under controlled lab conditions Quick Summary: BPC-157 is supplied as a 10mg lyophilized research compound
But by normalizing the cytokine environment and supporting proper T-cell differentiation, it may create conditions more favorable for tolerance induction